Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy

International Journal of Pharmaceutics

Volumn 280, Issue 1-2, 2004, Pages 103-111

  Sawada, Toyohiro ^a   Kondo, Hiromu ^a   Nakashima, Hiroshi ^a   Sako, Kazuhiro ^a   Hayashi, Masahiro ^b  

^a Fukuoka Institute of Technology   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Chronopharmacotherapy; Compression coated tablets; Dogs; Nifedipine; Time release formulation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; MACROGOL; NIFEDIPINE;

ANIMAL EXPERIMENT; ARTICLE; COMPRESSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; DRUG BLOOD LEVEL; DRUG COATING; DRUG ELIMINATION; DRUG FORMULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHRONOTHERAPY; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DOGS; MALE; NIFEDIPINE; TABLETS; TIME FACTORS;

EID: 3242740076     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.05.004     Document Type: Article

References (20)

1. Bevan A.T., Honour A.J., Stott F.H. Direct arterial pressure recording in unrestricted man. Clin. Sci. 36:1969;329-344
2. Coupe A.J., Davis S.S., Wilding I.R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 8:1991;360-364
3. Iga K., Ogawa Y., Yashiki T., Shimamoto T. Estimation of drug absorption rates using a deconvolution method with non-equal sampling time. J. Pharmacokinet. Biopharm. 14:1986;213-225
4. Kario K., Matsuo T., Kobayashi H., Imiya M., Matsuo M., Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Hypertension. 27:1996;130-135
5. Kario K., Pickering T.G., Umeda Y., Hoshide S., Hoshide Y., Morinari M., Murata M., Kuroda T., Schwartz J.E., Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation. 107:2003;1401-1406
6. Krögel I., Bodmeier R. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug. Pharm. Res. 15:1998;474-481
7. Lemmer B. Circadian rhythms and drug delivery. J. Control. Release. 16:1991;63-74
8. Nakamura K., Oita J., Yamaguchi T. Nocturnal blood pressure dip in stroke survivors. Stroke. 26:1995;1373-1378
9. Pickering T.G., James G.D. Determinants and consequences of the diurnal rhythm of blood pressure. Am. J. Hypertens. 6:1993;166S-169S
10. Rubinstein A., Tirosh B., Baluom M., Nassar T., David A., Radai R., Gliko-Kabir I., Friedman M. The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J. Control. Release. 46:1997;59-73
11. Sako K., Nakashima H., Sawada T., Fukui M. Relationship between gelation rate of controlled-release acetaminophen tablets containing polyethylene oxide and colonic drug release in dogs. Pharm. Res. 13:1996;594-598
12. Sawada T., Sako K., Yoshihara K., Nakamura K., Yokohama S., Hayashi M. Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam. J. Pharm. Sci. 92:2003a;790-797
13. Sawada T., Sako K., Fukui M., Yokohama S., Hayashi M. A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen. Int. J. Pharm. 265:2003b;55-63
14. Sugimoto I., Kuchiki A., Nakagawa H. Stability of nifedipine- polyvinylpyrrolidone coprecipitate. Chem. Pharm. Bull. 29:1981;1715-1723
15. Ueda Y., Hata T., Yamaguchi H., Kotani M., Ueda S. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. J. Drug Target. 2:1994;35-44
16. Uekama K., Ikegami K., Wang Z., Horiuchi Y., Hirayama F. Inhibitory effect of 2-hydroxypropyl-β-cyclodextrin on crystal-growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone K-30. J. Pharm. Pharmacol. 44:1992;73-78
17. White W.B. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press. Monit. 6:2001;63-72
18. White W.B., Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am. J. Cardiol. 63:1989;94-98
19. White W.B., Black H.R., Weber M.A., Elliott W.J., Bryzinski B., Fakouhi T.D. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am. J. Cardiol. 81:1998;424-431
20. Wilding I.R., Davis S.S., Sparrow R.A., Smith K.J., Sinclair K.A., Smith A.T. The evaluation of an enteric-coated naproxen tablet formulation using gamma scintigraphy. Eur. J. Pharm. Biopharm. 39:1993;144-147